Ignite Creation Date:
2024-05-06 @ 4:20 PM
Last Modification Date:
2024-10-26 @ 2:08 PM
Study NCT ID:
NCT04955990
Status:
TERMINATED
Last Update Posted:
2024-03-29
First Post:
2021-06-29
Brief Title:
A Study of Real-world Cohort of Pulmonary Arterial Hypertension PAH Participants
Sponsor:
Actelion
Organization:
Actelion
Study Overview
Official Title:
An International Non-Drug Interventional Real-world Cohort of PAH Patients Newly Initiating PAH Therapy With Guideline-directed Assessments of Disease Severity
Status:
TERMINATED
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
The sponsor decided to terminate the study
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CARE PAH
Brief Summary:
This study is designed to describe pulmonary arterial hypertension PAH participants in terms of their clinical characteristics therapies used disease progression and outcomes example death hospitalization risk category for predicted mortality risk and patient-reported outcomes PROs in real-world clinical practice This study will collect high-quality real-world data that may be used as a stand-alone dataset or in combination with other studies to address relevant research questions example serve as an external control dataset to another study to support development and access to PAH therapies as well as to contribute to the knowledge base of PAH through publications
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 67896062PAH4005 | OTHER | Actelion | None |